View the event
| Reference: | 3864 |
| Country: | Georgia |
| Multiple country event: | No |
| Region: | EURO |
| City: | Sukhumi |
| Start date: | 4 July 2011 |
| End date: | 8 July 2011 |
| Estimated duration: | |
| Status: | Completed - Complété |
| | (The mission has taken place) |
|
| Title: | GLC/Europe M&E mission |
| Type: | Mission |
| Terms of Reference: | Objectives:
• To assess implementation of the MDR-TB program and evaluate current achievements.
• To asses the need and readiness for expansion.
• To update enrolment plan of MDR TB patients in 2011.
• To assess the situation with drug procurement and supply management and update the request to IDA for SLD according elaborated enrolment plan
• To collect data on patients on treatment and specific regimens.
Key issues to be elaborated and reviewed:
1. Coordination between the project and the community, prison system, the NTP, the supranational reference laboratory and the second-line drug-procurement agency;
2. Case finding strategies.
3. Treatment strategies, administration and follow-up.
4. Management system for second-line TB drugs in terms of quantification method, procurement, importation, storage, distribution and delivery to the patients, and scale up plan for enrolment in the next 1 year period.
5. Current status of laboratory services, including country laboratory network, internal and external quality control and coordination with supranational laboratory.
6. Infection control strategies.
7. Coordination between TB/HIV and MDR-TB interventions.
8. Information system and data management.
9. Interim treatment outcomes (with outcomes report as per table in the attachment) and case-holding of patients currently enrolled.
Expected outcome of the mission
? Evaluation of the status of the program
? MSF possible support for the program
? Feasibility of application to The Global Fund, Round 11
|
| Training Opportunity: | No |
| Website: | |
| Purpose 1: | MDR-TB / XDR-TB |
| Purpose 2: | Drug and commodities management |
| Purpose 3: | Global Fund Processes |
| Other purpose: | |
|
| Entered by: | WHO/EURO |
| Partner 1: | |
| Partner 2: | |
| Partner 3: | |
| Contact name: | Ogtay Gozalov / Rusudan Klimiashvili |
| Contact email: | ogo@euro.who.int, ruk@euro.who.int |
| Other agencies: | |
|
| Funding needs: | No |
| Funding source: | Eli Lilly MDR Partnership |
| Other funding source: | |
| Available funding: | $ 0 |
| Funding gap: | $ 0 |
| Global Fund reference: | |
|
| Comments: | |
| |
|
Documents associated with this event |
| Mission Report - Rapport de la mission |
This document is not publicly available |
Confidential |
|
There are no experts (non-roster) associated with this event.
Date Created: 2 November 2011
Entered By: Europe Office (WHO)
|
